← All trials
NCT02231086
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2015
- Primary completion
- Apr 1, 2019
- Completion date
- Apr 1, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 176
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of AmsterdamLead sponsor
- ZonMw: The Netherlands Organisation for Health Research and DevelopmentCollaborator
- Dutch Health Care Insurance BoardCollaborator
- University of AmsterdamReponsible party - principal investigator
- University of AmsterdamOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.